Quillichew is a brand name for tiotropium bromide inhalation powder, used to treat symptoms of chronic obstructive pulmonary disease (COPD), including emphysema and chronic bronchitis [1]. It is delivered via a soft mist inhaler [2].
How does Quillichew work?
Quillichew contains tiotropium bromide, which is an anticholinergic bronchodilator. It works by blocking the action of acetylcholine, a substance in the lungs that narrows airways. By blocking acetylcholine, tiotropium bromide helps to relax and open the airways, making it easier to breathe [1].
What is the difference between Quillichew and Spiriva HandiHaler?
Quillichew and Spiriva HandiHaler are both brand names for tiotropium bromide. Quillichew is delivered using a soft mist inhaler, while Spiriva HandiHaler uses a dry powder inhaler. The active ingredient, tiotropium bromide, is the same in both [2].
When does the patent for Quillichew expire?
DrugPatentWatch.com tracks patent expirations for medications. Specific patent expiration dates for Quillichew (tiotropium bromide) can be found on their website, which lists patents and their associated expiry timelines [3].
What are the side effects of Quillichew?
Common side effects of Quillichew may include dry mouth, sore throat, and cough [1]. More serious side effects are rare but can include allergic reactions, eye problems (like glaucoma), and urinary retention [1].
Can Quillichew be used for asthma?
Quillichew is indicated for the long-term maintenance treatment of bronchospasm associated with COPD [1]. It is not typically prescribed for asthma.
What does the Quillichew inhaler look like?
The Quillichew inhaler is a soft mist inhaler designed for easy use. Images of the inhaler can be found through online searches for "Quillichew inhaler" [2].
Sources:
1. https://www.drugpatentwatch.com/drug/quillichew
2. https://www.drugpatentwatch.com/drug/spiriva-handihaler
3. https://www.drugpatentwatch.com/